Article 2021 · 22 citations

The <i>In Vitro</i> and <i>In Silico</i> Inhibition Mechanism of Glutathione Reductase by Resorcinol Derivatives: A Molecular Docking Study

Abstract

Glutathione reductase (GR), which is a major antioxidant enzyme, is targeted in the treatment of many diseases due to the dual role of its product, reduced glutathione (GSH), in infected cells. This study's goal was to introduce new GR inhibitors to the literature. The inhibition profiles of the inhibitor were studied via two different approaches: in vitro and in silico. To this end, firstly, GR was isolated from human erythrocytes, following which the in vitro inhibition impacts of resorcinol derivatives and in silico inhibition mechanisms of them were elucidated. GR was obtained with a specific activity of 12.49 EU/mg protein and a 27.67% yield. Afterward, IC50 values was found to range from 0.014 to 1.500 mM. The docking studies of the compounds were performed against hGR receptors, and 4-hexylresorcinol had the lowest docking score of similar to 4.276 kcal/mol. In conclusion, it was determined that 4-hexylresorcinol is the most effective inhibitor among resorcinol derivatives for human erythrocyte GR in accordance with both in vitro and in silico studies. 4-Hexylresorcinol may be utilized in drug design to target the recovery of GSH. (C) 2020 Elsevier B.V. All rights reserved.

Keywords

drug likeness glutathione reductase inhibition in silico resorcinol OXIDATIVE STRESS DRUG DISCOVERY DESIGN REDOX PURIFICATION MALARIA PROTEIN ABSORPTION ACTIVATION PREDICT

WoS Categories

Chemistry, Physical

Sustainable Development Goals

Good Health and Well-being

Citation

Journal: JOURNAL OF MOLECULAR STRUCTURE
Year: 2021
Volume: 1228
ISSN: 0022-2860
eISSN: 1872-8014
DOI: 10.1016/j.molstruc.2020.129790
WoS UID: WOS:000609159200003

Open via DOI